ClinConnect ClinConnect Logo
Search / Trial NCT06821516

Comparison of Pain Relief Methods for Hip Surgery: A Study on Two Different Nerve Block Techniques

Launched by BAŞAKŞEHIR ÇAM & SAKURA CITY HOSPITAL · Feb 9, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Pericapsular Nerve Group (Peng) Block Lumbar Erector Spinae Plane Block Total Hip Arthroplasty Postoperative Analgesia

ClinConnect Summary

This clinical trial is investigating two different methods of pain relief for patients undergoing total hip replacement surgery. The goal is to find out which technique—called the pericapsular nerve group block (PENG) or the lumbar erector spinae plane block (L-ESP)—provides better pain control after the surgery. Researchers will measure how much pain participants experience, how much pain medication they need, and how satisfied they are with their pain relief over the first 24 hours after the operation.

To be eligible for this study, participants must be over 18 years old and plan to have total hip arthroplasty (hip replacement surgery). They should be in generally good health (ASA score I-III) and able to follow instructions. Those who have serious health issues, certain infections, or allergies related to the pain relief methods will not be included. Participants can expect close monitoring of their pain levels and medication use after surgery, and they will complete a satisfaction questionnaire to help researchers understand which method works best for pain relief. Importantly, both methods are designed to effectively manage pain, so participants will receive proper pain management throughout the study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Voluntary willingness to participate in the study.
  • Patients who will undergo Total Hip Arthroplasty surgery.
  • Patients aged over 18 years.
  • ASA score I-II-III.
  • Patients who are fully oriented and can cooperate.
  • Exclusion Criteria:
  • ASA score IV-V.
  • Patients who refuse to participate in the study.
  • Patients under 18 years of age.
  • Presence of active infection in the area to be operated on.
  • Chronic pain and continuous analgesic use.
  • Patients with coagulation disorders.
  • Patients who cannot cooperate with postoperative pain follow-up.
  • Patients with allergies to local anesthetic agents.
  • Presence of neuropathy or myopathy in the operated extremity.

About Başakşehir çam & Sakura City Hospital

Başakşehir Çam & Sakura City Hospital is a leading healthcare institution in Turkey, renowned for its state-of-the-art facilities and commitment to patient-centered care. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical research and innovation across various therapeutic areas. With a multidisciplinary team of experts and a focus on ethical practices, Başakşehir Çam & Sakura City Hospital actively collaborates with industry partners and academic institutions to facilitate cutting-edge clinical trials, aiming to improve treatment outcomes and enhance the overall quality of healthcare.

Locations

İ̇stanbul, Türki̇ye, Turkey

İ̇stanbul, , Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported